The SLAS Finance Committee ensures that the society’s financial resources are used to advance the society’s tax exempt purposes by developing and recommending the SLAS annual budget for consideration and final approval by the SLAS Board of Directors. Throughout the fiscal year, the committee then monitors actual financial performance and compares it with the budget plan.
SLAS Treasurer and Chair
Peter Grandsard, Amgen
Scott Atkin, IOI Partners
Michele Cleary, The Mark Foundation for Cancer Research
Severine Tamas-Lhoustau, Novoptim
Cathy Tralau-Stewart, Takeda